Pomegranate Mood Randomized Trial: What the Evidence Says

Quick Answer

Pomegranate Mood Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• The clinical impact is meaningful, as bloating and gas-related symptoms are associated with reduced quality-of-life and higher levels of stress and anxiety. [Allegretti Jessica R. (2026); evidence level 2]
• Clinically, disruption of GI barrier function is linked to increased sensitivity to visceral and somatic stimuli. [Allegretti Jessica R. (2026); evidence level 2]
• The pathophysiology of T2DM and its associated complications is characterized by chronic systemic inflammation and oxidative stress (Balci et al. ; Basaran and Aktas ). [Zare Maryam (2025); evidence level 2]
• Recent evidence suggests that polyphenol-rich foods and supplements can significantly improve clinical outcomes in diabetic patients through their potent antioxidant and anti-inflammatory properties (Raimundo et al. ). [Zare Maryam (2025); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For pomegranate mood randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Allegretti Jessica R. (2026). A Randomized, Placebo-Controlled Trial Evaluating Multi-Species Synbiotic Supplementation for Bloating, Gas, and Abdominal Discomfort. DOI: 10.3390/nu18020255. PMCID: PMC12845427. PMID: 41599868. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12845427/
• Zare Maryam (2025). Effects of Bread Fortification With Pomegranate Peel Powder on Inflammation Biomarkers, Oxidative Stress, and Mood Status in Patients With Type 2 Diabetes: A Randomized Placebo‐Controlled Trial. DOI: 10.1002/fsn3.70577. PMCID: PMC12344722. PMID: 40808706. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12344722/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.